Tobias Riet

Robert Koch Str. 21
Koeln, NW 50931, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Overcoming fratricide of CD86 targeting CAR-T cells by defined logic-gate CAR strategy.

Overcoming fratricide of CD86 targeting CAR-T cells by defined logic-gate CAR strategy.

Journal: Experimental hematology & oncology

Published: January 05, 2026

CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma.

CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma.

Journal: Cancer cell

Published: August 25, 2024

Development of Beta-Amyloid-Specific CAR-Tregs for the Treatment of Alzheimer's Disease.

Development of Beta-Amyloid-Specific CAR-Tregs for the Treatment of Alzheimer's Disease.

Journal: Cells

Published: August 02, 2023

Generation of Chimeric Antigen Receptors against Tetraspanin 7.

Generation of Chimeric Antigen Receptors against Tetraspanin 7.

Journal: Cells

Published: March 05, 2023

Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application.

Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application.

Journal: Journal of autoimmunity

Published: December 15, 2022

An anti-CD19/CTLA-4 switch improves efficacy and selectivity of CAR T cells targeting CD80/86-upregulated DLBCL.

An anti-CD19/CTLA-4 switch improves efficacy and selectivity of CAR T cells targeting CD80/86-upregulated DLBCL.

Journal: Cell reports. Medicine

Published: September 22, 2022

Membrane-bound IL-2 improves the expansion, survival, and phenotype of CAR Tregs and confers resistance to calcineurin inhibitors.

Membrane-bound IL-2 improves the expansion, survival, and phenotype of CAR Tregs and confers resistance to calcineurin inhibitors.

Journal: Frontiers in immunology

Published: July 28, 2022

Regulatory CAR-T cells in autoimmune diseases: Progress and current challenges.

Regulatory CAR-T cells in autoimmune diseases: Progress and current challenges.

Journal: Frontiers in immunology

Published: May 02, 2022

Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies.

Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies.

Journal: Blood cancer discovery

Published: January 20, 2022

Coexpressed Catalase Protects Chimeric Antigen Receptor-Redirected T Cells as well as Bystander Cells from Oxidative Stress-Induced Loss of Antitumor Activity.

Coexpressed Catalase Protects Chimeric Antigen Receptor-Redirected T Cells as well as Bystander Cells from Oxidative Stress-Induced Loss of Antitumor Activity.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: July 08, 2015

Chimeric antigen receptor T cells: power tools to wipe out leukemia and lymphoma.

Chimeric antigen receptor T cells: power tools to wipe out leukemia and lymphoma.

Journal: Expert review of hematology

Published: May 08, 2015

Nonviral RNA transfection to transiently modify T cells with chimeric antigen receptors for adoptive therapy.

Nonviral RNA transfection to transiently modify T cells with chimeric antigen receptors for adoptive therapy.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: January 09, 2013

Showing 1-12 of 15

Last Updated: 09/26/2026